Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy J Davidoff

Showing results (91-100 of 120) with videos related to

Pageof 12
Sort By:
Cancer|June 17, 2017
Hypomethylating agent therapy use and survival in older patients with chronic myelomonocytic leukemia in the United States: A large population-based studyAmer M Zeidan, Xin Hu, Jessica B Long, et al.
Cancer|November 25, 2020
A framework for cancer health economics researchMichael T Halpern, Ya-Chen Tina Shih, K Robin Yabroff, et al.
Leukemia & Lymphoma|June 8, 2019
RBC transfusion independence among lower risk MDS patients receiving hypomethylating agents: a population-level analysisAmer M Zeidan, Weiwei Zhu, Maximilian Stahl, et al.
Medical Care|December 11, 2012
Use and spending on antineoplastic therapy for Medicare beneficiaries with cancerAmy J Davidoff, Thomas Shaffer, Mujde Z Erten, et al.
Journal of Geriatric Oncology|June 25, 2013
A novel approach to improve health status measurement in observational claims-based studies of cancer treatment and outcomesAmy J Davidoff, Ilene H Zuckerman, Naimish Pandya, et al.
Urology Practice|May 21, 2021
The Association Between the Affordable Care Act and Insurance Status, Stage and Treatment in Patients with Testicular CancerWalter Hsiang, Xuesong Han, Ahmedin Jemal, et al.
Blood Advances|May 23, 2020
Chromosome 1 abnormalities and survival of patients with multiple myeloma in the era of novel agentsSmith Giri, Scott F Huntington, Rong Wang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 14, 2019
Impact of Hydroxyurea on Survival and Risk of Thrombosis Among Older Patients With Essential ThrombocythemiaNikolai A Podoltsev, Mengxin Zhu, Amer M Zeidan, et al.
The Prostate|November 22, 2016
Myelodysplastic Syndromes and Acute Myeloid Leukemia After Radiotherapy for Prostate Cancer: A Population-Based StudyRong Wang, Amer M Zeidan, James B Yu, et al.
Blood Advances|October 19, 2018
The impact of phlebotomy and hydroxyurea on survival and risk of thrombosis among older patients with polycythemia veraNikolai A Podoltsev, Mengxin Zhu, Amer M Zeidan, et al.
Pageof 12

Showing results (91-100 of 120) with videos related to

Sort By:
Pageof 12
Cancer|June 17, 2017
Hypomethylating agent therapy use and survival in older patients with chronic myelomonocytic leukemia in the United States: A large population-based studyAmer M Zeidan, Xin Hu, Jessica B Long, et al.
Cancer|November 25, 2020
A framework for cancer health economics researchMichael T Halpern, Ya-Chen Tina Shih, K Robin Yabroff, et al.
Leukemia & Lymphoma|June 8, 2019
RBC transfusion independence among lower risk MDS patients receiving hypomethylating agents: a population-level analysisAmer M Zeidan, Weiwei Zhu, Maximilian Stahl, et al.
Medical Care|December 11, 2012
Use and spending on antineoplastic therapy for Medicare beneficiaries with cancerAmy J Davidoff, Thomas Shaffer, Mujde Z Erten, et al.
Journal of Geriatric Oncology|June 25, 2013
A novel approach to improve health status measurement in observational claims-based studies of cancer treatment and outcomesAmy J Davidoff, Ilene H Zuckerman, Naimish Pandya, et al.
Urology Practice|May 21, 2021
The Association Between the Affordable Care Act and Insurance Status, Stage and Treatment in Patients with Testicular CancerWalter Hsiang, Xuesong Han, Ahmedin Jemal, et al.
Blood Advances|May 23, 2020
Chromosome 1 abnormalities and survival of patients with multiple myeloma in the era of novel agentsSmith Giri, Scott F Huntington, Rong Wang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 14, 2019
Impact of Hydroxyurea on Survival and Risk of Thrombosis Among Older Patients With Essential ThrombocythemiaNikolai A Podoltsev, Mengxin Zhu, Amer M Zeidan, et al.
The Prostate|November 22, 2016
Myelodysplastic Syndromes and Acute Myeloid Leukemia After Radiotherapy for Prostate Cancer: A Population-Based StudyRong Wang, Amer M Zeidan, James B Yu, et al.
Blood Advances|October 19, 2018
The impact of phlebotomy and hydroxyurea on survival and risk of thrombosis among older patients with polycythemia veraNikolai A Podoltsev, Mengxin Zhu, Amer M Zeidan, et al.
Pageof 12